Anshul Specialty Molecules Private Limited - Company Profile

It is a chemicals and materials private limited company based in Mumbai, Maharashtra, India, established in 1971.
1971 Mumbai, Maharashtra, India Active
Last Updated:
About Anshul Specialty Molecules Private Limited

Anshul Specialty Molecules Private Limited, a active private limited company, was established on 05 October 1971 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24100MH1971PTC015364. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.94 M.

Formerly known as Anshul Specialty Molecules Limited. It upholds a compliant status. Employing 205 professional, Its leadership includes Ashwin Champraj Shroff (Director), Ravi Ashwin Shroff (Director), Shirish Ramchandra Satpute (Whole-Time Director). Past directors included Ashwin Champraj Shroff, Bahadur Vrajlal Gandhi, Usha Ashwin Shroff. It holds ₹57.27 Cr open charges and ₹3.49 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flexcel Park, C Wing, 2Nd Floor, S.V. Road, Near 24 Karat Multiplex, Joge, Shwari (W), Mumbai, Maharashtra, 400102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH1971PTC015364

  • Registration Number

    015364

  • Incorporation Date

    05 October 1971

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.94 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.94 M
  • Company Age 54 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 57.27 Cr
  • Satisfied Charges ₹ 3.49 Cr
  • Revenue Growth **** -8.89%
  • Profit Growth **** -48.97%
  • Ebitda **** -80.22%
  • Net Worth 4.63%
  • Total Assets **** 8.02%
Company report

Anshul Specialty Molecules Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Anshul Specialty Molecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Anshul Specialty Molecules Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashwin Champraj Shroff Director 14 Nov 2014 Current
Ravi Ashwin Shroff Director 09 Feb 2010 Current
Shirish Ramchandra Satpute Whole-Time Director 01 Apr 2022 Current
Ramchandra Neelkanth Bhogale Director 27 Nov 2025 Current
Hrishit Ashwin Shroff Director 27 Nov 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 20 Nov 2023 Past
Pramod Abcsdd Director 29 Apr 2019 Past
Pramod Abcsdd Additional Director 20 Apr 2008 Past
Pramod Abcsdd Director 01 Jul 2009 Past
Pramod Abcsdd Additional Director 01 Apr 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anshul Specialty Molecules.

Anshul Specialty Molecules Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.89% decrease. The company also saw a substantial fall in profitability, with a 48.97% decrease in profit. The company's net worth moved up by a moderate rise of 4.63%.

Anshul Specialty Molecules revenue growth over time
Anshul Specialty Molecules profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-8.89%
*******
*******
*******
*******
Revenue from Operations
*******
-16.45%
*******
*******
*******
*******
Total Assets
*******
8.02%
*******
*******
*******
*******
Profit or Loss
*******
-48.97%
*******
*******
*******
*******
Net Worth
*******
4.63%
*******
*******
*******
*******
EBITDA
*******
-80.22%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anshul Specialty Molecules?

In 2023, Anshul Specialty Molecules had a promoter holding of 100.00%. The company had 3 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹572,650,000.00

Satisfied Charges

₹34,940,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 56.77 Cr
  • Bank Of Baroda : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
16 Nov 2010 Bank Of India ₹4.95 Cr Open
08 Sep 2006 Bank Of India ₹25.88 Cr Open
19 Nov 2004 Bank Of India ₹25.88 Cr Open
23 Feb 1994 Bank Of Baroda ₹5.00 M Open
02 Jul 1985 Bank Of India ₹0.40 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Anshul Specialty Molecules?

Anshul Specialty Molecules has a workforce of 205 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Anshul Specialty Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anshul Specialty Molecules's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anshul Specialty Molecules
Recent Activity within the Organization
  • Director Appointment

    The activity Ramchandra Neelkanth Bhogale was appointed as a Director was appointed as a Director on 27 Nov 2025 & has been associated with this company since 2 months 17 days . was completed.

  • Director Appointment

    The activity Hrishit Ashwin Shroff was appointed as a Director was appointed as a Director on 27 Nov 2025 & has been associated with this company since 2 months 17 days . was completed.

  • Annual General Meeting

    Progress on Anshul Specialty Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Anshul Specialty Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge with Bank Of India of Rs. 25.88 Cr registered on 08 Sep 2006 with Charge ID 10022027 was modified on 28 Mar 2023. was documented.

  • Charges

    A charge with Bank Of India of Rs. 25.88 Cr registered on 19 Nov 2004 with Charge ID 90164523 was modified on 10 Jan 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Anshul Specialty Molecules Private Limited?

The CIN of Anshul Specialty Molecules Private Limited is U24100MH1971PTC015364.

Where is Anshul Specialty Molecules Private Limited headquartered?

Anshul Specialty Molecules Private Limited is headquartered at Flexcel Park, C Wing, 2Nd Floor, S.V. Road, Near 24 Karat Multiplex, Joge, Shwari (W), Mumbai, Maharashtra, 400102.

When was Anshul Specialty Molecules Private Limited incorporated?

Anshul Specialty Molecules Private Limited was incorporated on 05 October 1971.

Who are the current directors of Anshul Specialty Molecules Private Limited?

The current directors of Anshul Specialty Molecules Private Limited are

What is the primary industry of Anshul Specialty Molecules Private Limited?

The primary industry of Anshul Specialty Molecules Private Limited is Manufacturing.

Is Anshul Specialty Molecules Private Limited a listed company?

Anshul Specialty Molecules Private Limited is unlisted.

What is the capital structure of Anshul Specialty Molecules Private Limited?

The authorized capital of Anshul Specialty Molecules Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.94 M.

What is the compliance status of Anshul Specialty Molecules Private Limited?

The compliance status of Anshul Specialty Molecules Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available